| Sample | Title | Value | Rank |
|---|
| GSM132917 | SKI-DLCL cells_untreated_24h_1rpt | 832.4 | 94 |
| GSM132918 | SKI-DLCL cells_untreated_24h_2rpt | 828.4 | 93 |
| GSM132920 | SKI-DLCL cells_untreated_24h_rpt3 | 759.6 | 93 |
| GSM132941 | SKI-DLCL cells_Aplidin 3nM_24h_rpt1 | 849.8 | 94 |
| GSM132944 | SKI-DLCL cells_Aplidin 3.0nM_24h_rpt2 | 840.9 | 94 |
| GSM132947 | SKI-DLCL cells_Aplidin treated 3nM_24h_rpt3 | 930.3 | 94 |
| GSM132949 | SKI-DLCL cells_AraC 20nM_24h_rpt1 | 867.4 | 94 |
| GSM132950 | SKI-DLCL cells_AraC 20nM_24h_rpt2 | 903.5 | 94 |
| GSM132953 | SKI-DLCL cells_AraC 20nM_24h_rpt3 | 885.6 | 94 |
| GSM132955 | SKI-DLCL cells_Aplidin 1.5nM AraC 5nM_24h_rpt1 | 914.6 | 94 |
| GSM132956 | SKI-DLCL cells_Aplidin 1.5 nM AraC 5nM_24h_rpt2 | 1001.4 | 95 |
| GSM132960 | SKI-DLCL cells_Aplidin 1.5 nM AraC 5.0 nM_24h_rpt3 | 974.1 | 95 |
| GSM132760 | SKI-DLCL_tumor_untreated animals | 909.1 | 95 |
| GSM132916 | SKI-DLCL_tumor_animals treated with 1mg/kg Aplidin_50mg/kg AraC | 2986.4 | 98 |